Gene Hartline was diagnosed with sarcomatoid mesothelioma in 2016. He received chemo before he began the immunotherapy drug Opdivo. “They say now the cancer is in remission. I feel like 100 percent better than I did before,” Hartline said. “I almost feel like I got my life back. Who knows how long this will last, but I’m not going to sit here and let the grass grow under my feet.”
Every year, peritoneal mesothelioma survivor Trina West-Clark takes a trip to the casino to have a few cocktails with friends and celebrate another year…
Diagnosed with peritoneal mesothelioma at age 15, Alyssa Hankus’ adolescence was anything but normal. She missed nearly her entire freshman year of high…
Judy Goodson met her mesothelioma diagnosis with uncommon optimism. Instead of focusing on the prognosis or worst case scenario, she thoroughly researched…
Mesothelioma survivor Jim Madaris doesn’t worry about tomorrow anymore. He is too busy enjoying today, savoring triumphs large and small. He already has won…
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
Who Am I Calling?
Calling this number connects you with a Patient Advocate at The Mesothelioma Center, the nation's most trusted mesothelioma resource.
Our Patient Advocates can help guide you or your loved one through the steps to take after a mesothelioma diagnosis. Our team has a combined experience of more than 30 years in assisting cancer patients, and includes a medical doctor, an oncology registered nurse and a U.S. Navy veteran.
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Please read our editorial guidelines to learn more about our content creation and review process.
